Lenox Wealth Management’s Core Laboratories CLB Stock Holding History

Lenox Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-208	Closed	-$24K	–	643
2018 Q3	$24K	Sell	208 -58	-22%	-$6.54K	0.01%	300
2018 Q2	$34K	Sell	266 -282	-51%	-$34.3K	0.01%	241
2018 Q1	$59K	Buy	548 +266	+94%	+$29.4K	0.02%	195
2017 Q4	$31K	Buy	282 +1	+0.4%	+$100	0.01%	264
2017 Q3	$27K	Sell	281 -7	-2%	-$679	0.01%	285
2017 Q2	$29K	Sell	288 -68	-19%	-$7.33K	0.01%	260
2017 Q1	$41K	Sell	356 -428	-55%	-$49.7K	0.03%	98
2016 Q4	$94K	Sell	784 -197	-20%	-$21.8K	0.07%	62
2016 Q3	$110K	Buy	981 +165	+20%	+$19K	0.09%	53
2016 Q2	$101K	Sell	816 -39	-5%	-$4.71K	0.07%	64
2016 Q1	$96K	Sell	855 -247	-22%	-$25.7K	0.07%	65
2015 Q4	$120K	Buy	+1,102	New	+$126K	0.09%	55

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Lenox Wealth Management's CLB Position: Q4 2018 in Review

Lenox Wealth Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 208 shares — an estimated $24K sold.

Lenox Wealth Management first reported a position in CLB in Q4 2015 and held it in 12 quarters. The position peaked at $120K in Q4 2015. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Lenox Wealth Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Lenox Wealth Management sold 208 Core Laboratories shares in Q4 2018, an estimated $24K.
Lenox Wealth Management first reported a position in Core Laboratories in Q4 2015 and held it in 12 quarters.
Lenox Wealth Management's Core Laboratories position peaked at $120K in Q4 2015.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Lenox Wealth Management's 13F filing for Q4 2018, filed 23 Jan 2019.